PD‐L1 expression in ROS1‐rearranged non‐small cell lung cancer: A study using simultaneous genotypic screening of EGFR, ALK, and ROS1

BACKGROUND: The aim of the current study was to investigate the prevalence and clinicopathologic characteristics of ROS1‐rearranged non‐small cell lung cancer (NSCLC) in routine genotypic screening in conjunction with the study of PD‐L1 expression, a biomarker for first‐line treatment decisions. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jongmin, Park, Chan Kwon, Yoon, Hyoung‐Kyu, Sa, Young Jo, Woo, In Sook, Kim, Hyo Rim, Kim, Sue Youn, Kim, Tae‐Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312846/
https://www.ncbi.nlm.nih.gov/pubmed/30475455
http://dx.doi.org/10.1111/1759-7714.12917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312846/
https://www.ncbi.nlm.nih.gov/pubmed/30475455
http://dx.doi.org/10.1111/1759-7714.12917

Ejemplares similares